Promising Potential of Merus’s Petosemtamab in HNSCC: A Buy Recommendation
Bank of America Securities analyst Tazeen Ahmad maintained a Buy rating on Merus (MRUS – Research Report) yesterday and set a price target of ...
Citigroup Issues Positive Forecast for Merus (NASDAQ:MRUS) Stock Price
Merus (NASDAQ:MRUS – Get Free Report) had its price target hoisted by research analysts at Citigroup from $89.00 to $97.00 in ...
Merus (MRUS): FDA Approval and Speculative Future in Cancer Therapy
We recently published a list of Jim Cramer’s Lightning Rounds: 12 Stocks Under the Spotlight. In this article, we are going ...
Merus (NASDAQ:MRUS) Given “Buy” Rating at Needham & Company LLC
Needham & Company LLC reaffirmed their buy rating on shares of Merus (NASDAQ:MRUS – Free Report) in a report published on Monday,Benzinga reports. The firm currently has a $85.00 price target on the ...
Stifel Nicolaus Sticks to Their Buy Rating for Merus (MRUS)
Stifel Nicolaus analyst Bradley Canino maintained a Buy rating on Merus (MRUS – Research Report) today and set a price target of $96.00. The ...
Parsa Fallah scores 25 and Oregon State defeats Idaho 78-62
Get real-time COLLEGEBASKETBALL basketball coverage and scores as Idaho Vandals takes on Oregon State Beavers. We bring you the latest game previews, live stats, and recaps on CBSSports.com ...
OREGON STATE 78, IDAHO 62
Team Rebounds: 1. Team Turnovers: 1. Blocked Shots: 6 (Anderson, Gonzalez, Linhardt, Mims, Mrus). Turnovers: 15 (Anderson 2, Linhardt 2, Payne 2, Steele 2, Yearout 2, Brickner, Gonzalez, Klapper, ...
Oregon St. 78, Idaho 62
Fallah 10-16 5-8 25, Rataj 4-12 6-7 14, Kingz 3-8 2-2 9, Lelevicius 4-6 0-0 9, Minor 1-4 0-0 2, Lake 3-4 0-0 8, Sy 2-5 0-0 5, Craig 0-1 0-0 0, Marsh 2-3 0-0 4, Munch 0-1 0-0 0, Logue 0-1 0-0 0, Marrs ...
Merus Scores Its First FDA Approval For Lung Cancer Drug
Bizengri (zenocutuzumab-zbco) as the first and only treatment indicated for adults with pancreatic adenocarcinoma or ...
morningstar.com.au15d
Merus NV
Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as ...
news.stocktradersdaily18d
When (MRUS) Moves Investors should Listen
In any case, new support levels are usually revised to the database at the beginning of the next trading session. Short MRUS slightly under 49.51, target n/a, stop loss @ 49.65 Details The technical ...
Houston Chronicle19d
S. Utah 82, Idaho 67
Mims 4-10 1-1 9, Mrus 1-3 0-0 3, Brickner 0-3 0-0 0, K.Mitchell 2-7 2-2 6, Payne 5-9 0-0 12, Anderson 1-5 0-0 2, Gonzalez 2-4 3-4 7, Rose 5-8 2-2 14, Klapper 3-5 0-0 7, Yearout 2-3 2-3 7 ...